Atlas Trials

Suzhou Junjing BioSciences Co., Ltd.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Suzhou Junjing BioSciences Co., Ltd.

RecordFirmDate
A Study to Evaluate Safety , Efficacy and Pharmacokinetics of WJ01024 Tablets Combined With Ruxolitinib in Patients With Myelofibrosis (NCT06909136)Suzhou Junjing BioSciences Co., Ltd.2025-07-28
JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations (NCT06940401)Suzhou Junjing BioSciences Co., Ltd.2025-04-30
A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer (NCT05662670)Suzhou Junjing BioSciences Co., Ltd.2022-10-11
A Study Explore WJ01075 Tablets in Patients With Advanced Solid Tumors (NCT05470933)Suzhou Junjing BioSciences Co., Ltd.2022-08-23
A Study of WJ05129 in Advanced Malignant Solid Tumors (NCT05326035)Suzhou Junjing BioSciences Co., Ltd.2022-04-19
The Safety and Efficacy of Multiple-dose of WJ01024 in Subject With Advanced Cancer (NCT04991129)Suzhou Junjing BioSciences Co., Ltd.2021-09-10
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer (NCT04993391)Suzhou Junjing BioSciences Co., Ltd.2021-07-13

Track Suzhou Junjing BioSciences Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.